Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bumetanib injection (2ml: 1mg) approved and issued by the China Drug Administration.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bumetanib injection (2ml: 1mg) approved and issued by the China Drug Administration.